MeiraGTx Holdings (MGTX) EBITDA Margin (2019 - 2026)
MeiraGTx Holdings (MGTX) recorded EBITDA Margin of 39.26% in Q4 2025, up 172.12 percentage points from -132.86% a year earlier and up 10501.70 percentage points from the prior quarter.
MeiraGTx Holdings (MGTX) EBITDA Margin (2019 - 2026) Analysis & Trends
For FY2025, MeiraGTx Holdings reported EBITDA Margin of -114.79%, up 340.11 percentage points from FY2024.
- Annual EBITDA Margin has a five-year change of +260.35 percentage points (FY2020 to FY2025).
- Across earlier years, EBITDA Margin came in at -454.89% in FY2024 (+424.97 pp), -879.87% in FY2023 (-203.79 pp), -676.08% in FY2022 (-503.98 pp) and -172.10% in FY2021 (+203.03 pp).
- The Q4 2025 figure is the highest quarterly EBITDA Margin in data going back to Q1 2019.
- On a year-over-year basis, EBITDA Margin rose in five of the last eight quarters, with an average year-over-year change of -1180.24 percentage points.
- Peak year-over-year performance for EBITDA Margin in the last five years was a gain of 14010.80 percentage points in Q2 2025, against a drop of 14416.53 percentage points in Q2 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at -10462.44% (Q3 2025), -1127.15% (Q2 2025) and -1999.74% (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 54.65% |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 46.88% |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 40.75% |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 46.62% |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 50.63% |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 42.49% |
| 10 | MeiraGTx Holdings | 878.99 Mn | 583.51 Mn | 314.27 Mn | 77.06% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 77.06% |
| Mar 31, 2026 | -12,826.28% |
| Dec 31, 2025 | 39.63% |
| Sep 30, 2025 | -10,393.66% |
| Jun 30, 2025 | -1,119.62% |
| Mar 31, 2025 | -1,985.51% |
| Dec 31, 2024 | -131.56% |
| Sep 30, 2024 | -334.59% |
| Jun 30, 2024 | -15,041.13% |
| Mar 31, 2024 | -6,201.43% |
| Dec 31, 2023 | -1,939.61% |
| Sep 30, 2023 | -568.53% |
| Jun 30, 2023 | -713.73% |
| Mar 31, 2023 | -851.89% |
| Sep 30, 2022 | -431.48% |
| Jun 30, 2022 | -201.44% |
| Mar 31, 2022 | -472.50% |
| Dec 31, 2021 | -26.75% |
| Sep 30, 2021 | -295.26% |
| Jun 30, 2021 | -360.97% |
MeiraGTx Holdings EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=MGTX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "MGTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=MGTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();